Michael W. Pauciulo

Cincinnati Children's Hospital Medical Center — United States

Medicine · Health Sciences

35h-index6.6kcitations130works4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pulmonary Hypertension Research and Treatments(89), Parkinson's Disease Mechanisms and Treatments(15), Lysosomal Storage Disorders Research(13), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(11), RNA modifications and cancer(9)

Publications130 total

Sex-specific Differences in Eicosanoid and Bioactive Lipid Metabolites and Their Associations With Hemodynamic Parameters in Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine·2025
Comparative Metabolomic and Molecular Profiles in Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine·2025
Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension
Circulation·2025
Cellular Communication Network Protein 2 in the Right Ventricle of Pulmonary Arterial Hypertension
Pulmonary Circulation·2025Open Access
Sequencing and health data resource of children of African ancestry
2025Open Access
Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension
Science·2025· 31 citedOpen Access
P262: Transformative care through genome sequencing: Insights from the first 100 patients in the CincyKidsSeq Study
Genetics in Medicine Open·2025Open Access
Studying Rare Movement Disorders: From Whole-Exome Sequencing to New Diagnostic and Therapeutic Approaches in a Modern Genetic Clinic
Biomedicines·2024Open Access
Abstract 4140468: Tet Methylcytosine Dioxygenase 2 mutation drives a global hypermethylation signature in patients with pulmonary arterial hypertension resulting in a common T cell phenotype.
Circulation·2024
Abstract 4138731: Clonal Hematopoiesis of Indeterminant Potential is Associated with Pulmonary Arterial Hypertension
Circulation·2024
Abstract 4138019: eQTL Analysis of the PAH Biomarker CCN2 Identifies a Novel SNP that Associates with Survival
Circulation·2024
Role of Forkhead box F1 in the Pathobiology of Pulmonary Arterial Hypertension
2024· 2 citedOpen Access
Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension
Circulation·2024· 20 citedOpen Access
Equivalency of Multiple Biomarkers to Clinical Pulmonary Arterial Hypertension Survival Risk Models
CHEST Journal·2024· 4 citedOpen Access
Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension
Respiratory Research·2024· 3 citedOpen Access
Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension
Circulation·2024· 17 citedOpen Access
Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension
2024
GENETIC CONTROL OF LYSOSOMAL DYSFUNCTION REPROGRAMS INFLAMMATORY STEROL METABOLISM IN PULMONARY ARTERIAL HYPERTENSION
Journal of the American College of Cardiology·2024· 2 cited
Genetic regulation and targeted reversal of lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension
2024Open Access
Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in pulmonary arterial hypertension
2024· 5 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

William C. Nichols(46), Katie A. Lutz(15), Eric D. Austin(11), Richard C. Trembath(10), Wendy K. Chung(10), D. Dunbar Ivy(10), Rajiv D. Machado(8), Roy N. Alcalay(8), Karen Marder(8), Nathan Pankratz(8), Tatiana Foroud(8), Ankit A. Desai(8), Anna W. Coleman(7), Marc Humbert(6), Cheryl Waters(6), Stanley Fahn(6), Christopher J. Rhodes(6), Erika B. Rosenzweig(6), Na Zhu(6), Carrie L. Welch(6)